Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
100%
ER+ Breast Cancer
100%
Odds Ratio
100%
Neoadjuvant Endocrine Therapy
100%
Response Rate
75%
Monotherapy
37%
Endocrine Therapy
37%
Radiological Response
37%
Breast Reconstruction
37%
Clinical Response Rate
37%
Surgery Rates
25%
Aromatase Inhibitors
25%
Combination Chemotherapy
25%
Low Toxicity
25%
Statistical Model
12%
Prospective Randomized Trial
12%
Tumor
12%
Librarians
12%
Pathway Inhibitors
12%
Breast
12%
Neoadjuvant
12%
Adjuvant Therapy
12%
Neoadjuvant Trials
12%
Data Extraction
12%
Prognostic Biomarker
12%
Estrogen Receptor-positive
12%
P-12
12%
Data Synthesis
12%
MEDLINE
12%
Growth Factor Pathway
12%
Fixed Effects
12%
Exclusion Criteria
12%
Pathological Complete Response
12%
Random Effects
12%
Biomarker Combination
12%
PRISMA Guidelines
12%
Pooled Odds Ratios
12%
Combination of Therapies
12%
Ovid MEDLINE
12%
Neoadjuvant Strategy
12%
Adjuvant Setting
12%
Therapy Predictive
12%
Dual Combination Therapy
12%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
100%
Hormone Therapy
100%
Estrogen Receptor Positive Breast Cancer
100%
Odds Ratio
90%
Monotherapy
30%
Aromatase Inhibitor
20%
Combination Chemotherapy
20%
Biological Marker
10%
Clinical Trial
10%
Combination Therapy
10%
Arm
10%
Tumor
10%
Adjuvant Therapy
10%
Estrogen Receptor
10%
Tamoxifen
10%
Growth Factor
10%